Clinical Trial Update: A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial comparing multiple doses of intravitreal microplasmin to sham injection in diabetic macular edema. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• microplasmin (microplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2013-09-13